A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis
Clinical trial NCT02387801 · COMPLETED
Trial details
- NCT number
- NCT02387801
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.